Index of reports
> Cases with Extravasation (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vibativ (Telavancin) where reactions include extravasation. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Vibativ side effects in 78 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-30
Patient: 78 year old male, weighing 183.0 kg (402.6 pounds)
Reactions: Extravasation, Vomiting, Nausea, Chills, Blood Glucose Increased, Tremor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vibativ
Dosage: 1800 mg, total dose
Indication: Erysipelas
Start date: 2011-11-21
End date: 2011-11-21
Vibativ
Dosage: 1000 mg, total dose
Start date: 2011-11-22
End date: 2011-11-22
Vibativ
Dosage: 1800 mg, total dose
Start date: 2011-11-23
End date: 2011-11-23
Other drugs received by patient: Platelet Aggregation Inhibitors
Possible Vibativ side effects in 78 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-07
Patient: 78 year old male, weighing 183.0 kg (402.6 pounds)
Reactions: Extravasation, Vomiting, Nausea, Chills, Blood Glucose Increased, Tremor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vibativ
Dosage: 1800 mg, total dose
Indication: Erysipelas
Start date: 2011-11-21
End date: 2011-11-21
Vibativ
Dosage: 1000 mg, total dose
Start date: 2011-11-22
End date: 2011-11-22
Vibativ
Dosage: 1800 mg, total dose
Start date: 2011-11-23
End date: 2011-11-23
Other drugs received by patient: Platelets
|